Benzinga | Jun 10, 2021 07:27AM EDT

Berenberg Initiates Coverage On ACADIA Pharmaceuticals with Hold Rating, Announces Price Target of $29

Berenberg analyst Esther Hong initiates coverage on ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Hold rating and announces Price Target of $29.